Back to News
Market Impact: 0.3
Swedish Orphan Biovitrum (BIOVF) Tops Q3 Earnings and Revenue Estimates
Source: zacks.com
Corporate EarningsAnalyst EstimatesHealthcare & BiotechCompany Fundamentals
Swedish Orphan Biovitrum reported quarterly earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.62 by $0.09, or about 15%. Earnings were up from $0.64 per share a year earlier.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.35
Ticker Sentiment
SOBI0.50
More News
- SK Hynix third-quarter profit sharply beats estimates on AI memory boost
- SK Hynix Posts Record Profit Amid AI Rush
- Anthropic's IPO could be 'speculative fiction' or a 'generational moment' — investors are split
- Anthropic Gives Traders a Pure-Play Bet on Frontier AI
- VCs will make billions on Anthropic’s IPO, but Amazon is set to make much (much) more
- Analysis-Hold or sell? High Treasury yields spur US banks to rethink bond portfolios